Frenova Renal Research | Nephrology Associates, P.A.
Research site
Site insights
Top conditions
Top treatments
LNP023
BI 685509
Parent organization
This site is a part of Frenova Renal Research
Curious how this site stacks up to its peers?
Data sourced from clinicaltrials.gov
Active trials
2 of 7 total trials
The purpose of this study is to evaluate the long-term safety and tolerability, of open label iptacopan in primary IgA nephropathy participants who h...
Enrolling
Primary IgA Nephropathy
Drug: LNP023
The purpose of this study is to assess the safety and efficacy of up to 2 REACT/rilparencel injections in participants with T2DM and CKD.
Enrolling
Chronic Kidney Diseases
Type 2 Diabetes Mellitus
Biological: Renal Autologous Cell Therapy (REACT/ rilparencel)
Procedure: Sham Comparator
Trial sponsors
C
P
Clinical trials
Research sites
Resources
Legal
© Copyright 2026 Veeva Systems